乐观
$250.34
情景价格
$82.720
+1.423 (+1.72%)收盘时
Hamilton Lane Incorporated is a private markets investment company providing solutions to institutional and private wealth investors around the world. The Company offers a variety of investment solutions to address its clients' needs across a range of private markets, including private equity, private credit, real estate, infrastructure, real assets, growth equity, venture capital and impact. These solutions are constructed from a range of investment types, including primary investments in funds managed by third-party managers, direct investments alongside such funds and acquisitions of secondary stakes in such funds, with a number of its clients utilizing multiple investment types. These solutions are offered in a variety of formats, covering some or all phases of private markets investment programs, which include customized separate accounts, specialized funds, advisory services, distribution management, and reporting, monitoring, data and analytics.
Hamilton Lane Inc (HLNE) is currently priced at $82.27, which is significantly below the analyst price targets of $117 from Goldman Sachs and $131 from UBS. However, the stock has a low RSI of 41.54, indicating it is nearing oversold territory, which could suggest a potential rebound. The forward P/E ratio is 12.02, indicating it is relatively undervalued compared to its earnings growth potential. The main risk is the year-to-date decline of 39.80%, which reflects market concerns about its performance and could lead to further volatility.
Goldman Sachs
$117
2026-10-02
Goldman Sachs
2026-10-02
目标价
$117
Wells Fargo
$103
2026-10-01
Wells Fargo
2026-10-01
目标价
$103
UBS
$131
2026-08-05
UBS
2026-08-05
目标价
$131
Oppenheimer
$182
2026-08-05
Oppenheimer
2026-08-05
目标价
$182
Morgan Stanley
$123
2026-07-21
Morgan Stanley
2026-07-21
目标价
$123
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Cosette's New Oral Solution for Sjögren’s Disease Approved by FDA

Hamilton Lane Executive Co-Chairman to Retire

Hamilton Lane Executive Co-Chairman to Retire

Columbia Threadneedle and Hamilton Lane Collaborate on Innovative Investment Solutions

Alternative Asset Managers Report Strong Q2 Performance
Hamilton Lane Incorporated is a private markets investment company providing solutions to institutional and private wealth investors around the world. The Company offers a variety of investment solutions to address its clients' needs across a range of private markets, including private equity, private credit, real estate, infrastructure, real assets, growth equity, venture capital and impact. These solutions are constructed from a range of investment types, including primary investments in funds managed by third-party managers, direct investments alongside such funds and acquisitions of secondary stakes in such funds, with a number of its clients utilizing multiple investment types. These solutions are offered in a variety of formats, covering some or all phases of private markets investment programs, which include customized separate accounts, specialized funds, advisory services, distribution management, and reporting, monitoring, data and analytics. It operates in the Financials sector (INVESTMENT ADVICE industry).
Hamilton Lane Inc (HLNE) is currently priced at $82.27, which is significantly below the analyst price targets of $117 from Goldman Sachs and $131 from UBS. However, the stock has a low RSI of 41.54, indicating it is nearing oversold territory, which could suggest a potential rebound. The forward P/E ratio is 12.02, indicating it is relatively undervalued compared to its earnings growth potential. The main risk is the year-to-date decline of 39.80%, which reflects market concerns about its performance and could lead to further volatility.
5 analysts cover HLNE: 1 rate it Buy, 4 Hold and 0 Sell. The average price target is 182.67.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。